Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M I Ross

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
Annals of Surgical Oncology|February 25, 1999
Feasibility of breast conservation therapy in metachronous or synchronous bilateral breast cancerK M Heaton, G E Peoples, S E Singletary, et al.
Annals of Surgical Oncology|January 5, 2002
Utility of breast sentinel lymph node biopsy using day-before-surgery injection of high-dose 99mTc-labeled sulfur colloidC C Solorzano, M I Ross, E Delpassand, et al.
Annals of Surgical Oncology|April 13, 2000
Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical TrialC M Balch, S Soong, M I Ross, et al.
Annals of Surgical Oncology|June 16, 2001
Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastasesG Vlastos, M E Jean, A N Mirza, et al.
Annals of Surgical Oncology|December 30, 1998
Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancerH M Kuerer, L A Newman, B D Fornage, et al.
Nature Medicine|October 5, 2021
Neoadjuvant talimogene laherparepvec plus surgery versus surgery alone for resectable stage IIIB-IVM1a melanoma: a randomized, open-label, phase 2 trialR Dummer, D E Gyorki, J Hyngstrom, et al.
Annals of Surgical Oncology|March 22, 2001
Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomasC M Balch, S J Soong, T Smith, et al.
American Journal of Surgery|February 2, 1999
Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancerH M Kuerer, L A Newman, A U Buzdar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging systemA C Buzaid, M I Ross, C M Balch, et al.
Surgery|December 14, 2001
Evaluation and surgical resection of adrenal masses in patients with a history of extra-adrenal malignancyJ T Lenert, C C Barnett, A P Kudelka, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Annals of Surgical Oncology|February 25, 1999
Feasibility of breast conservation therapy in metachronous or synchronous bilateral breast cancerK M Heaton, G E Peoples, S E Singletary, et al.
Annals of Surgical Oncology|January 5, 2002
Utility of breast sentinel lymph node biopsy using day-before-surgery injection of high-dose 99mTc-labeled sulfur colloidC C Solorzano, M I Ross, E Delpassand, et al.
Annals of Surgical Oncology|April 13, 2000
Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical TrialC M Balch, S Soong, M I Ross, et al.
Annals of Surgical Oncology|June 16, 2001
Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastasesG Vlastos, M E Jean, A N Mirza, et al.
Annals of Surgical Oncology|December 30, 1998
Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancerH M Kuerer, L A Newman, B D Fornage, et al.
Nature Medicine|October 5, 2021
Neoadjuvant talimogene laherparepvec plus surgery versus surgery alone for resectable stage IIIB-IVM1a melanoma: a randomized, open-label, phase 2 trialR Dummer, D E Gyorki, J Hyngstrom, et al.
Annals of Surgical Oncology|March 22, 2001
Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomasC M Balch, S J Soong, T Smith, et al.
American Journal of Surgery|February 2, 1999
Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancerH M Kuerer, L A Newman, A U Buzdar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging systemA C Buzaid, M I Ross, C M Balch, et al.
Surgery|December 14, 2001
Evaluation and surgical resection of adrenal masses in patients with a history of extra-adrenal malignancyJ T Lenert, C C Barnett, A P Kudelka, et al.
Pageof 12